11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning
|Published in||Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2015, vol. 59, no. 3, p. 342-350|
|Abstract||Aim of the present study was to evaluate the usefulness of 11C-choline PET/CT for detecting lymphatic or haematogenous spread and for planning radiotherapy in patients with medium-to-high risk prostate cancer.|
This document has no fulltext available yet, but you can contact its author by using the form below.
|Research group||Groupe Miralbell Raymond (radio-oncologie) (685)|
|GARCIA, J R et al. 11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning. In: Quarterly Journal of Nuclear Medicine and Molecular Imaging, 2015, vol. 59, n° 3, p. 342-350. https://archive-ouverte.unige.ch/unige:75421|